Global Health Innovative Technology (GHIT) Fund

Global Health Innovative Technology (GHIT) Fund is dedicated to advancing global health through strategic investments in innovative technologies. As a leading non-profit organization based in Tokyo, Japan, GHIT Fund operates as a unique public-private partnership. This collaboration includes the Government of Japan (Ministry of Foreign Affairs and Ministry of Health, Labour and Welfare), several Japanese pharmaceutical and diagnostics companies, the Bill & Melinda Gates Foundation, Wellcome Trust, and the United Nations Development Programme.

Located at Ark Hills Sengokuyama Mori Tower 25F, 1-9-10 Roppongi, Minato-ku, Tokyo, 106-0032, JP, Global Health Innovative Technology (GHIT) Fund focuses on funding research and development of new anti-infectives and diagnostics. These efforts target diseases that disproportionately affect the developing world, ensuring that cutting-edge solutions reach those who need them most. Global Health Innovative Technology (GHIT) Fund plays a crucial role in fostering scientific advancements that address pressing global health challenges.

Global Health Innovative Technology (GHIT) Fund is committed to driving progress in global health through collaboration and innovation. The organization’s work supports the development of vaccines, drugs, and diagnostics, strengthening healthcare systems and improving lives worldwide. We invite the manager of Global Health Innovative Technology (GHIT) Fund to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and impact.